Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1

作者: Oliver Kaut , Ina Schmitt , Ullrich Wüllner

DOI: 10.1007/S10048-011-0308-3

关键词:

摘要: Multiple lines of evidence suggest a link between environmental toxins and Parkinson's disease (PD). Although numerous studies reported associations genetic variants in de-toxifying enzymes, i.e. cytochrome genes, with PD. Epigenetic modifications genes subsequent altered expression may confer yet unappreciated level susceptibility. We present genome-wide methylation analysis PD quantitative DNA levels 27.500 CpG sites representing 14.495 genes. found decreased the P450 2E1 gene increased CYP2E1 messenger RNA patients' brains, suggesting that epigenetic this contribute to

参考文章(17)
H. Braak, C. M. Müller, U. Rüb, H. Ackermann, H. Bratzke, R. A. I. de Vos, K. Del Tredici, Pathology associated with sporadic Parkinson’s disease — where does it end? Parkinson’s Disease and Related Disorders. pp. 89- 97 ,(2006) , 10.1007/978-3-211-45295-0_15
Andrew G. Riedl, Paul M. Watts, Peter Jenner, C. David Marsden, P450 enzymes and Parkinson's disease: the story so far. Movement Disorders. ,vol. 13, pp. 212- 220 ,(1998) , 10.1002/MDS.870130204
A. Jowaed, I. Schmitt, O. Kaut, U. Wullner, Methylation Regulates Alpha-Synuclein Expression and Is Decreased in Parkinson's Disease Patients' Brains The Journal of Neuroscience. ,vol. 30, pp. 6355- 6359 ,(2010) , 10.1523/JNEUROSCI.6119-09.2010
Melissa B. Ramocki, Huda Y. Zoghbi, Failure of neuronal homeostasis results in common neuropsychiatric phenotypes Nature. ,vol. 455, pp. 912- 918 ,(2008) , 10.1038/NATURE07457
H. Niazi Shahabi, D.R. Andersson, H. Nissbrandt, Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production. Synapse. ,vol. 62, pp. 379- 388 ,(2008) , 10.1002/SYN.20505
Mohammed Soutto, DunFa Peng, Mohammad Razvi, Petra Ruemmele, Arndt Hartmann, Albert Roessner, Regine Schneider-Stock, Wael El-Rifai, Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas Cancer. ,vol. 116, pp. 4033- 4042 ,(2010) , 10.1002/CNCR.25151
P.M Watts, A.G Riedl, D.C Douek, R.J Edwards, A.R Boobis, P Jenner, C.D Marsden, Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase. Neuroscience. ,vol. 86, pp. 511- 519 ,(1998) , 10.1016/S0306-4522(97)00649-0
H. Niazi Shahabi, L. Westberg, J. Melke, A. Håkansson, A. Carmine Belin, O. Sydow, L. Olson, B. Holmberg, H. Nissbrandt, Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population. Journal of Neural Transmission. ,vol. 116, pp. 567- 573 ,(2009) , 10.1007/S00702-009-0221-1
Andrew P. Feinberg, Phenotypic plasticity and the epigenetics of human disease Nature. ,vol. 447, pp. 433- 440 ,(2007) , 10.1038/NATURE05919
Kimberly D. Siegmund, Caroline M. Connor, Mihaela Campan, Tiffany I. Long, Daniel J. Weisenberger, Detlev Biniszkiewicz, Rudolf Jaenisch, Peter W. Laird, Schahram Akbarian, DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons PLoS ONE. ,vol. 2, pp. e895- ,(2007) , 10.1371/JOURNAL.PONE.0000895